Roche has no plans for job cuts and business is healthy
Swiss pharmaceutical company Roche is not planning job cuts and its business is healthy, CEO… Read More
Swiss pharmaceutical company Roche is not planning job cuts and its business is healthy, CEO… Read More
Roche and partner Alnylam said on Tuesday their experimental drug against high blood pressure was… Read More
Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront,… Read More
Roche launched the 330-patient trial in March as it joined other pharmaceutical companies seeking to… Read More
Roche’s head of diagnostics, said the company aims to more than double production of tests… Read More
The Swiss drugmaker is seeking to establish Xofluza, which has a list price of $150,… Read More
Roche is also testing Rozlytrek in cancers with additional genetic anomalies Read More
Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a… Read More
Roche’s donation will focus on patients who have developed resistance, or inhibitors, to current hemophilia… Read More
ZURICH: Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from… Read More
SHANGHAI: Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a… Read More
COPENHAGEN: Lung cancer patients on Roche's immune system-boosting drug Tecentriq lived on average 4.2 months… Read More
LONDON/ZURICH: Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3… Read More